| Literature DB >> 29439537 |
Yuka Miura1, Gojiro Nakagami2,3, Koichi Yabunaka4,5, Haruka Tohara6, Hiroshi Noguchi7, Taketoshi Mori8, Hiromi Sanada9,10.
Abstract
Prevention for aspiration pneumonia requires assessment of aspiration and adequate swallowing care. This randomized controlled trial aimed to investigate the effectiveness of ultrasound examination and recommendations for swallowing care for the reduction of aspiration and pharyngeal post-swallow residue as compared with standard swallowing care. Twenty-three participants were randomized to the intervention group and 23 to the control group. The intervention consisted of four ultrasound examinations during mealtimes and recommendations for swallowing care every 2 weeks during an 8 week period. No recommendations concerning swallowing care based on ultrasound examinations were provided to the control group. The frequency of aspiration or residue was defined as x/y × 100% when aspiration or residue were detected x times from y times concerning the total ultrasound measurements. The proportion of the residents with reduced frequency of aspiration which was detected by ultrasonography at eight weeks were 4.3% in the intervention group and 0% in the control group. The median reduction in the frequency of aspiration and residue in the intervention group was 31%, and that in the control group was 11%. In conclusion, swallowing care guided by frequent ultrasound examinations during mealtimes had a trend of reducing the frequency of aspiration and residue during an 8-week period in individuals relative to standard swallowing care alone.Entities:
Keywords: aspiration pneumonia; deglutition disorders; swallowing care; ultrasound
Year: 2018 PMID: 29439537 PMCID: PMC5872222 DOI: 10.3390/healthcare6010015
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Algorithm of recommendations for swallowing care.
Figure 2Participants Consort flow diagram. US: Ultrasound.
Baseline characteristics of the participants.
| Intervention Group | Control Group | ||
|---|---|---|---|
| ( | ( | ||
| Age (years), median (Q1, Q3) | 87 (82, 92) | 85 (77, 92) | 0.767 † |
| Females, | 20 (87.0) | 20 (87.0) | 1.000 ‡ |
| Cerebrovascular disease, | 7 (30.4) | 11 (47.8) | 0.227 § |
| History of aspiration pneumonia, | 5 (21.7) | 1 (4.35) | 0.187 ‡ |
| Body mass index, median (Q1, Q3) | 20.9 (18.8, 23.8) | 19.3 (18.0, 21.3) | 0.114 † |
| Charlson Comorbidity Index, median (Q1, Q3) | 1 (1, 2) | 2 (1, 3) | 0.042 † |
| Underwent FEES or VFSS, | 5 (21.7) | 3 (13.0) | 0.700 ‡ |
| Type of food | 0.711 ‡ | ||
| Regular, | 4 (17.4) | 4 (17.4) | |
| Chopped, | 5 (21.7) | 2 (8.70) | |
| Soft, | 10 (43.5) | 13 (56.5) | |
| Mousse, | 3 (13.0) | 4 (17.4) | |
| Other types, | 1 (4.35) | 0 (0.00) | |
| Required assistance for eating, | 8 (34.8) | 7 (30.4) | 0.753 § |
| Intensive-care group, | 6 (26.1) | 5 (21.7) | 0.730 § |
| Aspiration detected by US, | 2 (8.70) | 3 (13.0) | 1.000 ‡ |
| Residue detected by US, | 3 (13.0) | 7 (30.4) | 0.284 ‡ |
| Presence of dysphagia | |||
| With dysphagia, | 4 (17.4) | 9 (39.1) | 0.189 ‡ |
| Without dysphagia, | 19 (82.6) | 14 (60.9) |
FEES: fiberoptic endoscopic evaluation of swallowing; US: ultrasound; VFSS: videofluoroscopic swallowing study; Q1: first quartile; Q3: third quartile. † Wilcoxon rank sum test; ‡ Fisher’s exact test; § Chi-square test.
Distribution of the presence of dysphagia and follow-up results.
| Presence of Dysphagia | Intervention Group ( | Control Group ( | ||||
|---|---|---|---|---|---|---|
| Baseline | Follow-Up after 8 Weeks * | Baseline | Follow-Up after 8 Weeks * | |||
| With dysphagia, | 4 (17.4) | Reduced | 2 | 9 (39.1) | Reduced | 3 |
| Increased | 0 | Increased | 5 | |||
| Without dysphagia, | 19 (82.6) | Maintained | 12 | 14 (60.9) | Maintained | 12 |
| Increased | 5 | Increased | 2 | |||
* Only participants who undertook the follow-up ultrasound examinations are shown in the table.
Changes in the frequency of aspiration and residue in the intervention group.
| US Results | ID | Baseline | Follow-Up after 8 Weeks | Comparison | * Difference (%) |
|---|---|---|---|---|---|
| Aspiration | 19AL | 10/18 | 4/16 | Reduced | 31 |
| Residue | 19AL | 14/18 | 2/16 | Reduced | 65 |
| Residue | 17AL | 9/18 | 4/18 | Reduced | 28 |
One examination basically contains nine measurements. Baseline and follow-up examination were repeated twice over 2 days. Participants in whom aspiration or residue were detected more than twice in one examination were included in this table. Participants whose frequency of aspiration and residue were reduced at follow-up relative to baseline were labeled as “Reduced”. * For the participants who were labeled as Reduced, the differences in the frequency at baseline and follow-up were calculated.
Changes in the frequency of aspiration and residue in the control group.
| US Results | ID | Baseline | Follow-Up after 8 weeks | Comparison | * Difference (%) |
|---|---|---|---|---|---|
| Aspiration | 8BL | 3/18 | 3/9 | Increased | – |
| Aspiration | 7BH | 4/18 | 3/13 | Increased | – |
| Aspiration | 36BL | 2/15 | 3/18 | Increased | – |
| Residue | 36BL | 2/15 | 2/18 | Increased | – |
| Residue | 2BL | 2/18 | 0/18 | Reduced | 11 |
| Residue | 4BL | 2/18 | 0/18 | Reduced | 11 |
| Residue | 11BL | 2/18 | 0/18 | Reduced | 11 |
| Residue | 21BL | 2/18 | 2/12 | Increased | – |
| Residue | 39BL | 2/10 | 6/18 | Increased | – |
One examination basically consists of nine measurements. Baseline and follow-up examination were repeated twice over 2 days. Participants in whom aspiration or residue were detected more than twice in one examination were included in this table. Participants whose frequency of aspiration and residue were reduced at follow-up relative to baseline were labeled as “Reduced”, and the remaining participant as “Increased”. * For the participants who were labeled as Reduced, the differences in the frequency at baseline and follow-up were calculated.